CITADEL ADVISORS LLC 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:17 pm Sale | 2024-09-30 | 13G | Janux Therapeutics, Inc. JANX | CITADEL ADVISORS LLC | 1,021,403 2.000% | -2,104,494 (-67.32%) | Filing |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | CITADEL ADVISORS LLC | 3,125,897 6.800% | 999,762 (+47.02%) | Filing |
| 2023-07-10 4:01 pm Purchase | 2023-06-29 | 13G | Janux Therapeutics, Inc. JANX | CITADEL ADVISORS LLC | 2,126,135 5.100% | 2,126,135 (New Position) | Filing |